Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Dissecting Merck's "Gardasil for Boys" FDA Application
- Merck has filed an application with the FDA for the use of the HPV vaccine Gardasil in boys. The move was predicted by BNET on Nov. 14. It will likely spur two debates, one over the safety of the vaccine and another over whether Gardasil is actually cost-effective enough to...
- Blog posts 2009-01-06
Additional Resources
- VeriFone HPV-20. (Product Spotlight).(Brief Article)
- The HPV-20 is a system of hardware and software components that provides the ultimate in uptime and reliability for your Ruby. The HPV-20 is not mission critical and provides valuable functions such as immediate backup and restore capability of ... The HPV-20 is a...
- Research articles 2001-08-01
- EPA To Issue Proposed HPV Test Rule.(high production volume (HPV) chemicals)(Brief Article)
- THE ENVIRONMENTAL Protection Agency EPA expects to issue a proposed rule in December that would require chemical manufacturers to conduct basic health and environmental effects tests on high production volume HPV chemicals. The test rule THE ENVIRONMENTAL...
- Research articles 2000-12-04
- Gardasil-TM-, Merck's Investigational Cervical Cancer Vaccine, Produced High Anti-HPV Immune Response in Adolescents; Newest Data on Gardasil-TM- Presented at European Society of Pediatric Infectious Diseases
- VALENCIA, Spain -- GardasilTM, Merck & Co., Inc.'s investigational quadrivalent human papillomavirus HPV vaccine, produced higher anti-HPV immune responses among adolescent males and females compared to young women, according to a new study presented today. Gardasil is an investigational vaccine designed to prevent infection from four common HPV types -...
- Research articles 2005-05-19
- CMA, White House Dispute HPV Delays.(high production volume chemicals)(Brief Article)(Statistical Data Included)
- CMA is disputing a white house assertion that it supports EPA's request to delay testing of certain high production volume HPV chemicals. The delays result from efforts to appease animal rights groups, which have targeted Vice President Al Gore in a campaign against the use of...
- Research articles 1999-10-27
- Third Wave's HPV High-Risk Screening Test Achieves European CE Marking
- MADISON, Wis. -- Third Wave Technologies Inc. (NASDAQ: TWTI) today announced that the company's HPV high-risk screening test has achieved European CE Conformite Europeene Marking certification. The test detects the presence of 14 high-risk types of human papillomavirus, or HPV, the virus that causes nearly all cervical cancers. It is...
- Research articles 2007-12-05
- EPA Invites 900 Companies To Join in HPV Testing Program.
- ENVIRONMENTAL PROTECTION Agency last week sent letters to the CEOs of 900 US chemical companies inviting them to participate in a voluntary testing program for high production volume HPV chemicals. The companies either make or import the 2,8 ENVIRONMENTAL...
- Research articles 1998-10-26
- Socma Faults HPV Testing Initiative.
- Trade group says production volume is poor criterion for evaluating risks. ENVIRONMENTAL PROTECTION Agency's plan to require the industry to conduct basic health and environmental effects tests on most high-production-volume HPV industrial Trade group says production volume...
- Research articles 1998-12-21
- Industry Seeks Six-Week Extension For HPV Testing Program Sign-Up.
- THE CHEMICAL INDUSTRY is asking Environmental Protection Agency to extend the February 1, 1999, deadline for companies that want to participate in the voluntary high-production volume HPV chemical testing program. In a December 4 statement THE CHEMICAL...
- Research articles 1998-12-14
- ACA to organize HIPV in Chemicals workshop in April. (Markets).(Alliance for Chemical Awareness; high production volume (HPV) chemicals)(Brief Article)
- AN INTERACTIVE workshop for companies that manufacture or use high production volume HPV chemicals will be held in Baltimore, Md., in April by the Alliance for Chemical Awareness ACA. The workshop is designed to provide manufacturers with AN...
- Research articles 2002-02-25
- District Court Dismisses Activist HPV Suit. (Marketplace).(high-production-volume industrial chemicals)(Brief Article)
- A FEDERAL DISTRICT court has dismissed a lawsuit by animal-welfare activists that sought to force the Environmental Protection Agency EPA to issue data-collection rules for about 2,800-high-production-volume HPV industrial chemicals. The A FEDERAL DISTRICT court has dismissed...
- Research articles 2001-12-24
- HPV Deadline Extended.
- IN RESPONSE TO AN industry request, Environmental Protection Agency has extended the deadline for chemical companies to sign up for the voluntary High Production Volume HPV Challenge Program until March 15, 1999. Lynn Goldman, assistant adm IN RESPONSE...
- Research articles 1998-12-28
- GlaxoSmithKline and Merck & Co., Inc. Enter Cross-License and Settlement Agreement for HPV Vaccine Patents
- WHITEHOUSE STATION, N.J. & PHILADELPHIA -- Merck & Co., Inc. (NYSE: MRK) and GlaxoSmithKline (NYSE: GSK) have entered into a cross-license and settlement agreement for certain patent rights related to human papillomavirus ("HPV") vaccine. GSK will receive an upfront payment and royalties from Merck based upon sales of a HPV...
- Research articles 2005-02-02
- Molecular Diagnostics Congratulates Merck Scientists on the Advancement of Their New HPV Vaccine
- CHICAGO -- The head of Molecular Diagnostics, Inc. (OTCBB: MCDG.OB) Medical Advisory committee, Dr. George Gorodeski, M.D., Ph.D., Professor, Department of Reproductive Biology, Case Western Reserve University commented: "The news released on Thursday October 6th, by Merck Co. Inc. (NYSE: MRK) of a new anti HPV vaccine that could potentially...
- Research articles 2005-10-11
- GenoID Ltd. Picks up Frost & Sullivan Product Innovation Award for its Breakthrough HPV Test Kit.
- LONDON, November 13 /PRNewswire/ -- The 2006 Frost & Sullivan Product Innovation Award in the European molecular diagnostics market is presented to GenoID Ltd., for its innovative real-time human papillomavirus HPV test kit, which represent LONDON, November 13 /PRNewswire/ -- ...
- Research articles 2006-11-13
- EPA Recommends Cutting Animal Use for HPV Testing.(High Production Volume)(Statistical Data Included)
- THE CLINTON ADMINISTRATION is taking steps to minimize the use of laboratory animals in the High Production Volume HPV chemical testing program after animal welfare protesters demanding the change had dogged Vice President Al Gore's presidential THE CLINTON ADMINISTRATION is taking steps to...
- Research articles 1999-10-25
- Groups sue again for HPV testing rules. (Laws & Regulations)
- A coalition of animal rights groups has filed a lawsuit in a federal court against the EPA's voluntary testing initiative for high production volume HPV chemicals, which involves numerous chemical producers and users. The groups are seeking to force ... A coalition of animal rights...
- Research articles 2002-11-01
- Industry Claims EPA Employed Inaccurate Data for HPV Rule.(high production volume chemicals)(Brief Article)
- THE CHEMICAL industry charges that Environmental Protection Agency EPA used outdated and inaccurate data on worker exposure in a proposed rule that would require manufacturers to test 37 high production volume HPV chemicals for health effects. THE CHEMICAL industry charges that Environmental Protection...
- Research articles 2001-07-09
- Chemical Industry Moves Ahead With Voluntary Testing of HPV Materials.
- MORE THAN 220 US companies or groups of companies have voluntarily agreed to conduct environmental and health screening tests on 1,800 high production volume HPV industrial chemicals under a year-old industry-government research initiative. MORE THAN 220 US companies...
- Research articles 1999-11-08
- Potential Clinical Utility of Performing HPV Genotyping Test Featured in Study Reported in Journal of the National Cancer Institute; New Study Uses Roche Diagnostics' Test to Detect High-Risk Types of Human Papillomavirus
- PLEASANTON, Calif. -- Roche Diagnostics announced today that the results of the ALTS (ASCUS/LSIL Triage Study for Cervical Cancer) clinical trial, which were published in the July 20, 2005 issue of the Journal of the National Cancer Institute JNCI,(1) support the use of genotyping certain human papillomavirus HPV high-risk types...
- Research articles 2005-08-31
- << Previous
- page 1 of 1
- Next >>
